DB
TXG icon

Danske Bank’s 10x Genomics TXG Stock Holding History

Danske Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$6.52K – 1563
2025
Q4 		$6.52K Hold
400
– – ﹤0.01% 1348
2025
Q3 		$4.68K Hold
400
– – ﹤0.01% 1322
2025
Q2 		$4.63K Hold
400
– – ﹤0.01% 1358
2025
Q1 		$3.49K Hold
400
– – ﹤0.01% 1208
2024
Q4 		$5.74K Sell
400
-700
-64% -$11K ﹤0.01% 1186
2024
Q3 		$24.8K Sell
1,100
-500
-31% -$10.3K ﹤0.01% 1310
2024
Q2 		$31.1K Sell
1,600
-26,221
-94% -$687K ﹤0.01% 1019
2024
Q1 		$1.04M Buy
+27,821
New +$1.22M ﹤0.01% 820

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Danske Bank's TXG Position: Q1 2026 in Review

Danske Bank sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 400 shares — an estimated $6.52K sold.

Danske Bank first reported a position in TXG in Q1 2024 and held it in 8 quarters. The position peaked at $1.04M in Q1 2024. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Danske Bank reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 400 10x Genomics shares in Q1 2026, an estimated $6.52K.
  • Danske Bank first reported a position in 10x Genomics in Q1 2024 and held it in 8 quarters.
  • Danske Bank's 10x Genomics position peaked at $1.04M in Q1 2024.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.